In a phase 2, randomized, double-blind, placebo-controlled trial of 10 g RM-131 involving 204 patients with diabetic gastroparesis (12% type 1 diabetes mellitus, 88% type 2 diabetes mellitus), with a 28-day treatment period after a 1-week, single-blinded, placebo run-in, RM-131 enhanced gastric emptying and reduced vomiting episodes and vomiting severity
Provided in lyophilised (freeze-dried) form for long-term storage and analytical consistency
For a strong immune response, balancing antioxidants and free radicals is essential
Q: Will this scrub clean my pores
Charlotte Gurr Further reading Prostate cancer and MS drugs approved by NICE This week, NICE also recommended talazoparib (Talzenna, Pfizer), alongside enzalutamide (Xtandi